Clinical TrialsSearch results
Number of results: 761
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Recruiting
- JCOG2103: Randomized phase III study comparing systemic therapy and debulking surgery consisting of primary tumor resection with systemic therapy alone for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination
- non-small-cell lung cancer
- WATANABE Shun-ichi
- 2023-02-28
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Recruiting
- JCOG2108: A multicenter randomized phase III study of systemic chemotherapy followed by maintenance therapy versus local consolidation therapy for postoperative oligometastatic recurrent non-small cell lung cancer
- Non-small cell lung cancere
- Watanabe Shun-ichi
- 2023-11-24
Other
- Phase II study of docetaxel, cisplatin, and zoledronic acid for advanced non-small cell lung cancer with bone metastases
- non-small cell lung cancer with bone metastases
- Thoracic Oncology Division, National Cancer Center Hospital East
- 2007-06-07
Other
- A Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
- Non-small cell lung cancer harboring activating EGFR or HER2 kinase domain mutations
- Isui Ayako
- 2022-11-22
Other
- A combination phase II study of gemcitabine and S-1 for platinum-refractory patients with non-small cell lung cancer (TORG 0705)
- Non-small cell lung cancer
- Thoracic Oncology Research Group
- 2007-12-01
Other
- Biweekly Paclitaxel+Carboplatin for elderly patients with untreated nonresectable non-small cell lung cancer
- Non-small cell lung cancer
- Keio University School of Medicine Division of Pulmonary Medicine
- 2008-08-23
Other
- Clinical study of a combined use of Gefitinib and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.
- non-small cell lung cancer
- Juntendo University, School of Medicine
- 2007-03-16
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22